Last Week’s Top-3 Most Read Posts On Pulmonary Fibrosis

by Marta Ribeiro | November 23, 2015

1. Esbriet’s Promise and Potential as a PF Therapy

2. IPF Experts Discuss Disease Diagnosis and Treatment at CHEST 2015

3. Boehringer Ingelheim’s OFEV (Nintedanib) IPF Therapy Reinforces Efficacy and Safety Profile in New Studies

Print This Page

About the Author

Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.